Ulbig M - Search Results

1

Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.

Kook D, Wolf A, Kreutzer T, Neubauer A, Strauss R, Ulbig M, Kampik A, Haritoglou C. Kook D, et al. Among authors: ulbig m. Retina. 2008 Oct;28(8):1053-60. doi: 10.1097/IAE.0b013e318176de48. Retina. 2008. PMID: 18779710

2

Topography of diabetic macular oedema compared with fluorescein angiography.

Neubauer AS, Chryssafis C, Priglinger SG, Haritoglou C, Thiel M, Welge-Lüssen U, Kampik A, Ulbig MW. Neubauer AS, et al. Among authors: ulbig mw. Acta Ophthalmol Scand. 2007 Feb;85(1):32-9. doi: 10.1111/j.1600-0420.2006.00727.x. Acta Ophthalmol Scand. 2007. PMID: 17244207 Free article.

3

Laser treatment in diabetic retinopathy.

Neubauer AS, Ulbig MW. Neubauer AS, et al. Ophthalmologica. 2007;221(2):95-102. doi: 10.1159/000098254. Ophthalmologica. 2007. PMID: 17380063 Free article. Review.

4

Comparison of intravitreal bevacizumab versus triamcinolone for the treatment of diffuse diabetic macular edema.

Kreutzer TC, Al Saeidi R, Kook D, Wolf A, Ulbig MW, Neubauer AS, Haritoglou C. Kreutzer TC, et al. Ophthalmologica. 2010;224(4):258-64. doi: 10.1159/000284466. Epub 2010 Feb 17. Ophthalmologica. 2010. PMID: 20160463 Free article.

5

Inhibitory activity of ranibizumab, sorafenib, and pazopanib on light-induced overexpression of platelet-derived growth factor and vascular endothelial growth factor A and the vascular endothelial growth factor A receptors 1 and 2 and neuropilin 1 and 2.

Kernt M, Thiele S, Neubauer AS, Koenig S, Hirneiss C, Haritoglou C, Ulbig MW, Kampik A. Kernt M, et al. Among authors: ulbig mw. Retina. 2012 Sep;32(8):1652-63. doi: 10.1097/IAE.0b013e318240a558. Retina. 2012. PMID: 22466477

6

Comparative evaluation of combined navigated laser photocoagulation and intravitreal ranibizumab in the treatment of diabetic macular edema.

Liegl R, Langer J, Seidensticker F, Reznicek L, Haritoglou C, Ulbig MW, Neubauer AS, Kampik A, Kernt M. Liegl R, et al. Among authors: ulbig mw. PLoS One. 2014 Dec 26;9(12):e113981. doi: 10.1371/journal.pone.0113981. eCollection 2014. PLoS One. 2014. PMID: 25541960 Free PMC article.

7

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.

Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A. Haritoglou C, et al. Among authors: ulbig m. Retina. 2006 Nov-Dec;26(9):999-1005. doi: 10.1097/01.iae.0000247165.38655.bf. Retina. 2006. PMID: 17151486 Clinical Trial.

8

Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.

Mayer WJ, Remy M, Wolf A, Kook D, Kampik A, Ulbig M, Reznicek L, Haritoglou C. Mayer WJ, et al. Among authors: ulbig m. Ophthalmologica. 2012;228(2):110-6. doi: 10.1159/000338732. Epub 2012 Jun 23. Ophthalmologica. 2012. PMID: 22739239 Free article.

9

Alterations of vascular pigment epithelium detachments associated with age-related macular degeneration during upload with intravitreal ranibizumab.

Wolf A, Rüping J, Neubauer AS, Mayer W, Ulbig M, Haritoglou C, Holz FG, Eter N, Kampik A. Wolf A, et al. Among authors: ulbig m. Retina. 2013 Oct;33(9):1843-9. doi: 10.1097/IAE.0b013e318287d9be. Retina. 2013. PMID: 23598795

10

Microaneurysm formation rate as a predictive marker for progression to clinically significant macular edema in nonproliferative diabetic retinopathy.

Haritoglou C, Kernt M, Neubauer A, Gerss J, Oliveira CM, Kampik A, Ulbig M. Haritoglou C, et al. Among authors: ulbig m. Retina. 2014 Jan;34(1):157-64. doi: 10.1097/IAE.0b013e318295f6de. Retina. 2014. PMID: 23792485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

192 results

Search Page